<?xml version="1.0" encoding="UTF-8"?>
<ref id="B159-vaccines-08-00224">
 <label>159.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Maude</surname>
    <given-names>S.L.</given-names>
   </name>
   <name>
    <surname>Laetsch</surname>
    <given-names>T.W.</given-names>
   </name>
   <name>
    <surname>Buechner</surname>
    <given-names>J.</given-names>
   </name>
   <name>
    <surname>Rives</surname>
    <given-names>S.</given-names>
   </name>
   <name>
    <surname>Boyer</surname>
    <given-names>M.</given-names>
   </name>
   <name>
    <surname>Bittencourt</surname>
    <given-names>H.</given-names>
   </name>
   <name>
    <surname>Bader</surname>
    <given-names>P.</given-names>
   </name>
   <name>
    <surname>Verneris</surname>
    <given-names>M.R.</given-names>
   </name>
   <name>
    <surname>Stefanski</surname>
    <given-names>H.E.</given-names>
   </name>
   <name>
    <surname>Myers</surname>
    <given-names>G.D.</given-names>
   </name>
   <etal/>
  </person-group>
  <article-title>Tisagenlecleucel in Children and Young Adults with B-Cell 
   <italic>4</italic>Lymphoblastic Leukemia
  </article-title>
  <source>N. Engl. J. Med.</source>
  <year>2018</year>
  <volume>378</volume>
  <fpage>439</fpage>
  <lpage>448</lpage>
  <pub-id pub-id-type="doi">10.1056/NEJMoa1709866</pub-id>
  <pub-id pub-id-type="pmid">29385370</pub-id>
 </element-citation>
</ref>
